MarkClydeGebhardtMD

Musculoskeletal Oncology/Cancer, Pediatric Orthopedics

Frederic W. and Jane M. Ilfeld Professor of Orthopedic Surgery, Beth Israel Deaconess Medical Center

Dr. Gebhardt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
330 Brookline Ave
# Bidmc
Boston, MA 02215
Phone+1 617-667-2140

Fax+1 617-667-0227

Dr. Mark Gebhardt is an orthopedic surgeon in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Massachusetts General Hospital, and Dartmouth-Hitchcock Medical Center. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 42 years. He specializes in musculoskeletal oncology/cancer and pediatric orthopedics and is experienced in musculoskeletal oncology and pediatric orthopaedics.

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Orthopaedic Surgery, 1978 - 1981
UPMC Medical Education (Pittsburgh)Residency, Surgery, 1975 - 1977
University of Cincinnati College of MedicineClass of 1975

PubMed

Management of limb length discrepancy after bone sarcoma resection about the knee in the skeletally immature.
Sean P Kelly, Dipak B Ramkumar, Brooke Crawford, Santiago A Lozano-Calderon, Mark C Gebhardt
Journal of Pediatric Orthopedics. Part B. 2024-09-01
2 citations
What is the Value of Radiology Input During a Multidisciplinary Orthopaedic Oncology Conference?
Aparna Komarraju, Eddy Zandee Van Rilland, Mark C Gebhardt, Megan E Anderson, Carrie Heincelman
Clinical Orthopaedics and Related Research. 2023-10-01
1 citations
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors.
Raja Shaikh, Brent R Weil, Christopher B Weldon, Nan Chen, Wendy B London
Cancer Medicine. 2023-06-01

Other

Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histology
Gebhardt MC, Wang LL, Chintagumpala M
http://www.uptodate.com/contents/osteosarcoma-epidemiology-pathogenesis-clinical-presentation-diagno
UpToDate, Wolters Kluwer Health - 2012-05-31
Treatment of the Ewing sarcoma family of tumors
Gebhardt MC, Harmon DC
http://www.uptodate.com/contents/treatment-of-the-ewing-sarcoma-family-of-tumors
UpToDate, Wolters Kluwer Health - 2012-12-11
Local treatment for primary soft tissue sarcoma of the extremities and chest wall
Gebhardt MC, Harmon DC, DeLaney TF
http://www.uptodate.com/contents/local-treatment-for-primary-soft-tissue-sarcoma-of-the-extremities-
UpToDate, Wolters Kluwer Health - 2013-04-10
Treatment of locally recurrent and unresectable, locally advanced soft tissue sarcoma of the extremities
Gebhardt MC, Harmon DC, DeLaney TF
http://www.uptodate.com/contents/treatment-of-locally-recurrent-and-unresectable-locally-advanced-so
UpToDate, Wolters Kluwer Health - 2013-01-18
Join now to see all

Generations of Excellence in Caring for Childhood Bone Cancers: Dr. Gebhardt and Dr. AndersonDecember 9th, 2021
TheFace: Sara Almoosa, Saudi Marketing DirectorJanuary 10th, 2020
Beware of Studies Claiming That Social Factors Are “Independently Associated” with Biological Complications of SurgerySeptember 16th, 2019
Join now to see all